Adipotide Research: What Published Studies Describe

For laboratory and research use only. Not for human consumption.

Adipotide, also referenced in the literature by the laboratory designation FTPP, is a synthetic peptide that has appeared in published research investigating the vascular supply of white adipose tissue. This overview summarizes how the research literature describes its studied mechanism and the type of study models in which it has been examined. Nothing here describes or implies any outcome in humans.

Key facts: Adipotide (FTPP) is a synthetic peptide studied in published research as a targeted pro-apoptotic compound investigated in models of white adipose tissue vasculature, where it is described as binding a prohibitin-associated site on the endothelial cells that supply blood to fat tissue. Published research on Adipotide has largely been conducted in animal models, including non-human primate obesity research, rather than in human clinical settings. It is available from Optimized Aminos strictly for laboratory and research use, with no claims made about outcomes in any living organism.

What Adipotide Is in the Research Literature

Adipotide is described in published research as a synthetic peptide constructed from two functional components: a targeting sequence reported to home in on a prohibitin-associated binding site expressed on the surface of blood vessel endothelial cells within white adipose tissue, and a second sequence associated with triggering localized programmed cell death (apoptosis) in the cells it binds. This two-part design is why Adipotide is frequently categorized in the literature as a "targeted pro-apoptotic peptide" rather than a hormone or receptor agonist in the sense that GH-axis or metabolic secretagogue peptides are.

Mechanism Described in Published Studies

Vascular Targeting in Adipose Tissue

Research literature describes the proposed mechanism as vasculature-selective: rather than acting broadly across the body, Adipotide's targeting domain is reported to concentrate the compound's activity on the specific blood vessel network that supplies white adipose tissue. Published study models describe a reduction in that local vascular supply following exposure, which researchers have used as the basis for studying downstream changes in adipose tissue mass in animal models.

Apoptotic Signaling Component

The second functional component of the molecule is described in the literature as a pro-apoptotic peptide sequence, which is reported to initiate programmed cell death specifically in the endothelial cells bound by the targeting domain. Researchers studying this mechanism have generally framed it as a localized, vasculature-restricted effect rather than a systemic one, distinguishing Adipotide's studied profile from broader anti-angiogenic compounds examined elsewhere in the literature.

Research Model Context

Published Adipotide research has been concentrated in animal models, most notably obesity research conducted in non-human primates, alongside earlier rodent-model studies establishing the underlying targeting mechanism. These publications describe changes measured in adipose tissue volume and related markers within the specific animal models studied. This body of literature has not been used to make or support any claim about outcomes in humans, and none of the material on this page should be read as describing or implying a human outcome.

Because Adipotide sits at the intersection of vascular biology and metabolic research, it is often discussed alongside other compounds studied in metabolic research contexts. Researchers comparing study designs across this space may find our roundup of research peptides to watch in 2026 useful for situating Adipotide relative to other actively studied compounds, including metabolically framed peptides like the one profiled on our Retatrutide listing.

Terminology and Documentation Notes

Adipotide is sometimes cross-referenced in supplier catalogs and literature indexes under the designation FTPP. Researchers cataloging this compound alongside others in a lab inventory may find it helpful to consult our 150-term peptide chemistry glossary for definitions of terms like "pro-apoptotic domain," "targeting sequence," and "vascular endothelium" as they appear across the broader peptide research literature, along with background on how synthetic research peptides like this one are produced at the bench level.

How Adipotide Is Positioned Among Other Studied Compounds

Within the broader catalog of research peptides examined for metabolic and mitochondrial research purposes, Adipotide occupies a distinct niche because its studied mechanism operates on vascular tissue rather than on a hormone receptor or an intracellular energy-sensing pathway. This sets it apart from compounds like the one described in our MOTS-c vs. NAD+ mitochondrial research comparison, which are studied for their role in cellular energy metabolism rather than tissue-specific vascular targeting. Researchers building a comparative literature review across metabolically framed peptides may find it useful to catalog Adipotide separately from AMPK- or NAD+-pathway compounds for exactly this reason — the mechanisms are not interchangeable even when the downstream research questions (adipose tissue biology, metabolic regulation) overlap.

Handling and Sourcing Considerations

As with any lyophilized research peptide, Adipotide requires careful concentration documentation before it is logged into a study protocol. Our reconstitution calculator computes the resulting concentration (mg/mL) from a given vial mass and diluent volume, strictly for laboratory record-keeping. Before adding Adipotide or any research compound to an order, confirm the accompanying documentation against a batch-specific Certificate of Analysis; our testing page outlines the third-party methods used to verify identity and purity on every listing in our catalog, and our note on whether research peptides are legal in 2026 covers the current regulatory framing for RUO compounds like this one.

Frequently Asked Questions

What is Adipotide studied for in the research literature?

Published research describes Adipotide as a synthetic peptide investigated in models of white adipose tissue vasculature, where it is reported to target and induce localized apoptosis in the blood vessel endothelial cells that supply fat tissue. This research has been conducted in laboratory and animal models.

Is Adipotide the same thing as FTPP?

FTPP is a designation used in the literature and in supplier catalogs to reference the same compound generally known as Adipotide. The two names are used interchangeably in published research and cataloging contexts.

Has Adipotide been studied in humans?

Published Adipotide literature has largely centered on animal research models, including non-human primate studies. This article makes no claims about outcomes in humans and is intended for research and educational purposes only.

How is Adipotide's mechanism described relative to other metabolic research peptides?

Unlike hormone-receptor agonists studied in metabolic research, Adipotide is described in the literature as a targeted pro-apoptotic peptide acting on adipose tissue vasculature specifically, rather than on a systemic metabolic or endocrine receptor pathway.

What documentation should accompany a research order of Adipotide?

A batch-specific Certificate of Analysis referencing a named independent testing lab and methods such as HPLC and mass spectrometry should accompany any Adipotide research order, consistent with documentation standards for other research peptides.